Evidence map›Paper›PMID 40558566›Full record

ArticleCells2025

Muscle Spatial Transcriptomic Reveals Heterogeneous Profiles in Juvenile Dermatomyositis and Persistence of Abnormal Signature After Remission.

Margot Tragin, Séverine A Degrelle, Baptiste Periou, Brigitte Bader-Meunier, Christine Barnerias, Christine Bodemer, Isabelle Desguerre, Mathieu Paul Rodero, François Jérôme Authier, Cyril Gitiaux

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Margot TraginBioinformatics Facilities Imagine Institute, SFR Necker, 75015 Paris, France.ORCID 0000-0003-1425-6480
Séverine A DegrelleInovarion, 75005 Paris, France.ORCID 0000-0001-6263-4875
Baptiste PeriouService d'Histologie, AP-HP, Hôpital Henri Mondor, 4010 Créteil, France.ORCID 0009-0008-0811-3612
Brigitte Bader-MeunierDepartment of Pediatric Immunology-Hematology and Rheumatology, Necker Enfants Malades Hospital, AP-HP Centre-Paris University, 75015 Paris, France.
Christine BarneriasHôpital Necker-Enfants Malades, 149 Rue de Sèvres, 75015 Paris, France.
Christine BodemerHôpital Necker-Enfants Malades, 149 Rue de Sèvres, 75015 Paris, France.
Isabelle DesguerreHôpital Necker-Enfants Malades, 149 Rue de Sèvres, 75015 Paris, France.
Mathieu Paul RoderoLaboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Université Paris Cité, 75006 Paris, France.
François Jérôme AuthierService d'Histologie, AP-HP, Hôpital Henri Mondor, 4010 Créteil, France.ORCID 0000-0002-0182-2052
Cyril GitiauxHôpital Necker-Enfants Malades, 149 Rue de Sèvres, 75015 Paris, France.

Funding

Agence Nationale de la Recherche (ANR) via project JDMINF2 ANR-21-CE17-0025research grant from Association Française contre les Myopathies (AFM), Pole Translamuscle (project number 2946).RHU CARMMA (ANR-15-RHUS-0003)
6 · The paper itself

Abstract

This study aimed to investigate the spatial heterogeneity of molecular signature in the muscle of juvenile dermatomyositis (JDM) patients before and after treatment. Unsupervised reference-free deconvolution of spatial transcriptomics and standardized morphometry were performed in two JDM muscle biopsies with different clinical severity at disease onset and compared to healthy muscle. Identified signatures were scored in two additional JDM muscle biopsies from the same patient before and after remission. Disappearance of the normal muscle signature mostly corresponding to mitochondrial biology was observed in JDM. Three pathological transcriptomic signatures were isolated, related to "myofibrillar stress", "muscle remodeling" and "interferon signaling" signatures. The "myofibrillar stress signature" was prominent in the most severe biopsy while the "muscle remodeling" signature was mostly present in the biopsy from the patient with good outcome. These signatures unveiled genes not previously associated with JDM including ANKRD1 and FSLT1 for "myofibrillar stress" and "muscle remodeling" signatures, respectively. Post-treatment analysis of muscle after two years remission showed a persistence of pathological signatures. This pilot study of JDM muscle identified spatially distributed pathological signatures that persist after remission. This work paves the way for a better understanding of the pathophysiology in affected muscle and the identification of biomarkers that predict relapse.

Indexed as

DermatomyositisMuscle, SkeletalTranscriptomeAdolescentBiopsyChildChild, PreschoolFemaleGene Expression ProfilingHumansMalePilot ProjectsRemission Inductioninterferonjuvenile dermatomyositismitochondrial dysfunctionmuscle spatial transcriptomicvisium

Identifiers

PMID40558566
PMCPMC12190613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.